|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
BR112014005355B1
(pt)
|
2011-09-08 |
2022-03-29 |
Yeda Research An Development Co., Ltd |
Células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
EP3115457B1
(en)
|
2014-03-05 |
2019-10-02 |
National University Corporation Kobe University |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
US11390921B2
(en)
|
2014-04-01 |
2022-07-19 |
Adaptive Biotechnologies Corporation |
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
|
|
IL313845A
(en)
|
2014-04-23 |
2024-08-01 |
Juno Therapeutics Inc |
Methods for enriching or producing immune cell populations for adoptive therapy
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
KR20170075013A
(ko)
|
2014-10-31 |
2017-06-30 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Cart 세포에서 유전자 발현의 변경 및 그의 용도
|
|
WO2016089433A1
(en)
|
2014-12-03 |
2016-06-09 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
|
US10765699B2
(en)
|
2015-02-06 |
2020-09-08 |
National University Of Singapore |
Methods for enhancing efficacy of therapeutic immune cells
|
|
AU2016243583B2
(en)
*
|
2015-03-27 |
2022-03-10 |
President And Fellows Of Harvard College |
Modified T cells and methods of making and using the same
|
|
KR102888521B1
(ko)
|
2015-04-06 |
2025-11-19 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna
|
|
CA2988854A1
(en)
|
2015-05-08 |
2016-11-17 |
President And Fellows Of Harvard College |
Universal donor stem cells and related methods
|
|
US11179448B2
(en)
|
2015-07-16 |
2021-11-23 |
Yeda Research And Development Co. Ltd. |
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
|
|
GB2557123B
(en)
|
2015-07-31 |
2021-11-03 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
ES2883116T3
(es)
|
2015-10-05 |
2021-12-07 |
Prec Biosciences Inc |
Meganucleasas diseñadas con secuencias de reconocimiento encontradas en el gen de la región constante alfa del receptor de células T humanas
|
|
EP4108255A1
(en)
|
2015-10-05 |
2022-12-28 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
WO2017090761A1
(ja)
|
2015-11-27 |
2017-06-01 |
国立大学法人神戸大学 |
標的化したｄｎａ配列の核酸塩基を特異的に変換する、単子葉植物のゲノム配列の変換方法、及びそれに用いる分子複合体
|
|
CN108884140B
(zh)
|
2015-12-03 |
2022-10-25 |
朱诺治疗学股份有限公司 |
修饰的嵌合受体及相关组合物和方法
|
|
CN108699557B
(zh)
|
2015-12-04 |
2025-08-15 |
诺华股份有限公司 |
用于免疫肿瘤学的组合物和方法
|
|
KR102883915B1
(ko)
|
2015-12-16 |
2025-11-18 |
시애틀 프로젝트 코포레이션 |
신생항원 동정, 제조, 및 용도
|
|
WO2017192536A1
(en)
|
2016-05-02 |
2017-11-09 |
University Of Kansas |
Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
MX2019000251A
(es)
|
2016-07-05 |
2019-10-09 |
Univ Johns Hopkins |
Composiciones y metodos que comprenden mejoras de los arn guias de crispr usando el promotor h1.
|
|
MX2019000188A
(es)
*
|
2016-07-05 |
2019-06-20 |
Univ Johns Hopkins |
Composiciones y metodos basados en crispr/cas9 para el tratamiento del cancer.
|
|
CN106191062B
(zh)
*
|
2016-07-18 |
2019-06-14 |
广东华南疫苗股份有限公司 |
一种tcr-/pd-1-双阴性t细胞及其构建方法
|
|
AU2017306557B2
(en)
|
2016-08-03 |
2023-08-03 |
Washington University |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
JP7215808B2
(ja)
|
2016-08-12 |
2023-01-31 |
ツールゲン インコーポレイテッド |
操作された免疫調節エレメントおよび変更された免疫
|
|
IL308824A
(en)
*
|
2016-08-17 |
2024-01-01 |
Factor Bioscience Inc |
Nucleic acid products and methods of administration thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
CN106480097A
(zh)
*
|
2016-10-13 |
2017-03-08 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9技术敲除人PD‑1基因构建可靶向MSLN新型CAR‑T细胞的方法及其应用
|
|
CN106399375A
(zh)
*
|
2016-08-31 |
2017-02-15 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9敲除人PD‑1基因构建靶向CD19CAR‑T细胞的方法
|
|
EP3519433A1
(en)
*
|
2016-10-03 |
2019-08-07 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
|
GB2573406B
(en)
|
2016-10-18 |
2021-11-10 |
Univ Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
CN111344396A
(zh)
*
|
2016-10-27 |
2020-06-26 |
因提玛生物科学公司 |
制备遗传修饰细胞的病毒方法
|
|
CA3038917A1
(en)
|
2016-11-07 |
2018-05-11 |
Genovie Ab |
An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
|
|
JP6858266B2
(ja)
*
|
2016-11-07 |
2021-04-14 |
ジェノヴィー エービーＧｅｎｏｖｉｅ Ａｂ |
Ｔ細胞レセプター、ｔ細胞抗原及びそれらの機能的相互作用の同定及び特徴決定のための遺伝子操作された多成分システム
|
|
CA3039420A1
(en)
|
2016-11-07 |
2018-05-11 |
Genovie Ab |
A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
|
|
GB201622044D0
(en)
*
|
2016-12-22 |
2017-02-08 |
Ucl Business Plc |
T cell-targeted T cells
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
AU2018208614A1
(en)
*
|
2017-01-10 |
2019-07-11 |
The General Hospital Corporation |
Modified T cells and methods of their use
|
|
WO2018132508A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Methods and compositions relating to ex vivo culture and modulation of t cells
|
|
IL268126B2
(en)
*
|
2017-01-18 |
2024-02-01 |
Yeda Res & Dev |
Genetically engineered Veto cells and their uses in immunotherapy
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
BR112019019005A2
(pt)
*
|
2017-03-14 |
2020-04-14 |
Sara Elizabeth Church |
métodos para armazenagem criogênica
|
|
KR20190130608A
(ko)
*
|
2017-03-22 |
2019-11-22 |
노파르티스 아게 |
면역종양학을 위한 조성물 및 방법
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US10934336B2
(en)
|
2017-04-13 |
2021-03-02 |
The Trustees Of The University Of Pennsylvania |
Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy
|
|
WO2018204493A1
(en)
*
|
2017-05-04 |
2018-11-08 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for gene editing in t cells using crispr/cpf1
|
|
CA3062698A1
(en)
*
|
2017-05-08 |
2018-11-15 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
CN110914431B
(zh)
|
2017-05-08 |
2024-04-19 |
株式会社图尔金 |
经人工操纵的免疫细胞
|
|
BR112019023608A2
(pt)
|
2017-05-12 |
2020-05-26 |
Crispr Therapeutics Ag |
Materiais e métodos para células manipuladas e seus usos em imuno-oncologia
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
US20200179450A1
(en)
*
|
2017-06-12 |
2020-06-11 |
Emory University |
T-cell antigen targeted chimeric antigen receptor (car) and uses in cell therapies
|
|
SG11201912179SA
(en)
|
2017-06-15 |
2020-01-30 |
Univ California |
Targeted non-viral dna insertions
|
|
WO2018236909A1
(en)
*
|
2017-06-20 |
2018-12-27 |
La Jolla Institute For Allergy And Immunology |
Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis
|
|
US20200181608A1
(en)
*
|
2017-06-20 |
2020-06-11 |
Jiangsu Hengrui Medicine Co., Ltd. |
METHOD FOR KNOCKING OUT TARGET GENE IN T CELL IN VITRO AND crRNA USED IN THE METHOD
|
|
JP2020529834A
(ja)
|
2017-06-30 |
2020-10-15 |
プレシジョン バイオサイエンシズ，インク． |
Ｔ細胞受容体アルファ遺伝子の改変されたイントロンを含む遺伝子改変ｔ細胞
|
|
JP2020530307A
(ja)
|
2017-06-30 |
2020-10-22 |
インティマ・バイオサイエンス，インコーポレーテッド |
遺伝子治療のためのアデノ随伴ウイルスベクター
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
CN111247241A
(zh)
|
2017-08-10 |
2020-06-05 |
新加坡国立大学 |
T细胞受体缺陷型嵌合抗原受体t细胞和其使用方法
|
|
EP3441461A1
(en)
*
|
2017-08-11 |
2019-02-13 |
Baylor College of Medicine |
Cd1d-restricted nkt cells as a platform for off-the-shelf cancer immunotherapy
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
CN109456943A
(zh)
*
|
2017-09-06 |
2019-03-12 |
亘喜生物科技（上海）有限公司 |
通用型嵌合抗原受体t细胞制备技术
|
|
US20200261502A1
(en)
*
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
CN109517796A
(zh)
*
|
2017-09-18 |
2019-03-26 |
博雅辑因（北京）生物科技有限公司 |
一种基因编辑t细胞及其用途
|
|
CN111148533A
(zh)
|
2017-09-19 |
2020-05-12 |
麻省理工学院 |
用于嵌合抗原受体t细胞疗法的组合物及其用途
|
|
CN109517820B
(zh)
*
|
2017-09-20 |
2021-09-24 |
北京宇繁生物科技有限公司 |
一种靶向HPK1的gRNA以及HPK1基因编辑方法
|
|
CN107630006B
(zh)
*
|
2017-09-30 |
2020-09-11 |
山东兴瑞生物科技有限公司 |
一种制备tcr与hla双基因敲除的t细胞的方法
|
|
EP3692063A1
(en)
*
|
2017-10-03 |
2020-08-12 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
|
EP3702454A4
(en)
|
2017-10-10 |
2021-08-04 |
Hiroshima University |
METHOD FOR GENERATING ANTIGEN-SPECIFIC REGULATORY T-CELLS (TREG) WITH EFFECTOR T-CELL (TEFF) ANTIGEN RECEPTORS
|
|
CN111479830A
(zh)
*
|
2017-10-10 |
2020-07-31 |
国立大学法人广岛大学 |
使用铂talen的t细胞受体的完全取代技术
|
|
WO2019075112A1
(en)
|
2017-10-10 |
2019-04-18 |
Gritstone Oncology, Inc. |
IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS
|
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
CN107759699A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd30抗原的转基因t细胞及其制备方法与应用
|
|
CN107759700A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd19抗原的转基因t细胞及其制备方法与应用
|
|
CN107827989A
(zh)
*
|
2017-10-18 |
2018-03-23 |
银丰生物工程集团有限公司 |
靶向骨髓瘤bcma抗原的转基因t细胞及其制备方法与应用
|
|
CN107723275B
(zh)
*
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
WO2019084552A1
(en)
|
2017-10-27 |
2019-05-02 |
The Regents Of The University Of California |
TARGETED REPLACEMENT OF ENDOGENIC T CELL RECEPTORS
|
|
RU2020116585A
(ru)
|
2017-10-30 |
2021-12-01 |
Пэкт Фарма, Инк. |
Редактирование гена первичных клеток
|
|
CN107916269B
(zh)
*
|
2017-11-17 |
2020-12-11 |
山东兴瑞生物科技有限公司 |
靶向cd19的tcr基因、制备方法、具有该基因的质粒、试剂盒及应用
|
|
KR20260008173A
(ko)
|
2017-11-22 |
2026-01-15 |
시애틀 프로젝트 코포레이션 |
신생항원에 대한 접합 에피토프 제시 감소
|
|
WO2019106163A1
(en)
*
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
CA3085338A1
(en)
*
|
2017-12-11 |
2019-06-20 |
Editas Medicine, Inc. |
Cpf1-related methods and compositions for gene editing
|
|
US11738047B2
(en)
|
2017-12-12 |
2023-08-29 |
The Trustees Of The University Of Pennsylvania |
Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof
|
|
US20190175651A1
(en)
*
|
2017-12-13 |
2019-06-13 |
Janssen Biotech, Inc. |
Immortalized car-t cells genetically modified to elminate t-cell receptor and beta 2-microglobulin expression
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
JP7372920B2
(ja)
*
|
2017-12-29 |
2023-11-01 |
セレクティス |
Ｃａｒ ｔ細胞の作製を改良するための方法
|
|
WO2019139987A1
(en)
|
2018-01-09 |
2019-07-18 |
Elstar Therapeutics, Inc. |
Calreticulin binding constructs and engineered t cells for the treatment of diseases
|
|
CN108559760A
(zh)
*
|
2018-01-09 |
2018-09-21 |
陕西师范大学 |
基于CRISPR靶向基因组修饰技术建立荧光素酶knock-in细胞系的方法
|
|
EP4006153B1
(en)
|
2018-01-12 |
2024-07-03 |
Curocell Inc. |
Enhanced immune cells using dual shrna and composition including the same
|
|
EP3765054A4
(en)
*
|
2018-01-19 |
2022-01-12 |
The Trustees Of The University Of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T LYMPHOCYTES USING CHIMERIC ANTIGEN RECEPTORS
|
|
CN108103027B
(zh)
*
|
2018-02-02 |
2021-12-24 |
中国医学科学院血液病医院（血液学研究所） |
高效率血细胞重编程同时实现基因编辑的方法
|
|
AU2019216982B2
(en)
*
|
2018-02-11 |
2024-07-04 |
Memorial Sloan-Kettering Cancer Center |
Non-HLA restricted T cell receptors and uses thereof
|
|
IL276839B1
(en)
|
2018-02-27 |
2026-05-01 |
Gritstone Bio Inc |
Neoantigen identification using pan-allelic models
|
|
WO2019173324A1
(en)
|
2018-03-06 |
2019-09-12 |
The Trustees Of The University Of Pennsylvania |
Prostate-specific membrane antigen cars and methods of use thereof
|
|
WO2019191114A1
(en)
|
2018-03-27 |
2019-10-03 |
The Trustees Of The University Of Pennsylvania |
Modified immune cells having enhanced function and methods for screening for same
|
|
WO2019186274A2
(en)
|
2018-03-30 |
2019-10-03 |
University Of Geneva |
Micro rna expression constructs and uses thereof
|
|
SG11202009761YA
(en)
|
2018-04-02 |
2020-10-29 |
Pact Pharma Inc |
Peptide-mhc compacts
|
|
CN112566698A
(zh)
|
2018-04-05 |
2021-03-26 |
朱诺治疗学股份有限公司 |
T细胞受体和表达该t细胞受体的工程化细胞
|
|
EP3775238A1
(en)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
|
AU2019247199A1
(en)
|
2018-04-05 |
2020-10-15 |
Editas Medicine, Inc. |
T cells expressing a recombinant receptor, related polynucleotides and methods
|
|
JP7304888B2
(ja)
|
2018-04-12 |
2023-07-07 |
プレシジョン バイオサイエンシズ，インク． |
ヒトｔ細胞受容体アルファ定常領域遺伝子に特異性を有する最適化された操作されたヌクレアーゼ
|
|
CN108490174B
(zh)
*
|
2018-04-18 |
2022-06-24 |
上海尚珞生物医药科技有限公司 |
检测car-t细胞的方法及其应用
|
|
SG11202010577YA
(en)
*
|
2018-04-26 |
2020-11-27 |
Baylor College Medicine |
Auto/allo-immune defense receptors for the selective targeting of activated pathogenic t cells and nk cells
|
|
EP3790629A1
(en)
|
2018-05-11 |
2021-03-17 |
CRISPR Therapeutics AG |
Methods and compositions for treating cancer
|
|
EP3794130A4
(en)
|
2018-05-16 |
2022-07-27 |
Synthego Corporation |
METHODS AND SYSTEMS FOR DESIGNING AND USING GUIDE RNA
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
CN112867498A
(zh)
*
|
2018-05-31 |
2021-05-28 |
华盛顿大学 |
使用嵌合抗原受体基因组编辑和转导t细胞以用于治疗t和b细胞恶性肿瘤的方法
|
|
IL279063B2
(en)
*
|
2018-05-31 |
2026-05-01 |
Washington Univ |
Chimeric antigen receptor T cells for cancer treatment
|
|
CN110616188B
(zh)
*
|
2018-06-20 |
2023-05-09 |
上海隆耀生物科技有限公司 |
一种通用型car-t细胞及其制备方法和应用
|
|
WO2020010250A2
(en)
|
2018-07-03 |
2020-01-09 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
US20220347213A1
(en)
*
|
2018-08-08 |
2022-11-03 |
Nantbio, Inc. |
Recombinant CD1-Restricted T Cells And Methods
|
|
CN110904045A
(zh)
*
|
2018-09-17 |
2020-03-24 |
中国科学院动物研究所 |
经修饰的t细胞、其制备方法及用途
|
|
KR20210065141A
(ko)
*
|
2018-09-21 |
2021-06-03 |
카파 테라퓨틱스 리미티드 |
CRISPR/Cas 시스템을 기반으로 한 세포의 유전자 편집 방법
|
|
JP7250031B2
(ja)
*
|
2018-09-25 |
2023-03-31 |
公益財団法人微生物化学研究会 |
新規ウイルスベクターおよびその製造方法と使用方法
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
CN109295106B
(zh)
*
|
2018-09-30 |
2020-07-24 |
北京鼎成肽源生物技术有限公司 |
一种hafft1细胞
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
MX2021004214A
(es)
*
|
2018-10-16 |
2021-07-15 |
Intellia Therapeutics Inc |
Composiciones y metodos de inmunoterapia.
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
WO2020095249A1
(en)
*
|
2018-11-07 |
2020-05-14 |
Crispr Therapeutics Ag |
Anti-liv1 immune cell cancer therapy
|
|
WO2020095248A1
(en)
*
|
2018-11-07 |
2020-05-14 |
Crispr Therapeutics Ag |
Anti-ptk7 immune cell cancer therapy
|
|
US20220226375A1
(en)
*
|
2018-11-07 |
2022-07-21 |
Crispr Therapeutics Ag |
Anti-cd33 immune cell cancer therapy
|
|
WO2020103013A1
(en)
*
|
2018-11-21 |
2020-05-28 |
Nanjing Bioheng Biotech Co., Ltd |
Modified t cells and uses thereof
|
|
US11793834B2
(en)
|
2018-12-12 |
2023-10-24 |
Kite Pharma, Inc. |
Chimeric antigen and T cell receptors and methods of use
|
|
CN109722437B
(zh)
*
|
2018-12-29 |
2020-01-07 |
广州百暨基因科技有限公司 |
一种通用型car-t细胞及其制备方法和用途
|
|
CN109652378B
(zh)
*
|
2018-12-29 |
2020-04-24 |
广州百暨基因科技有限公司 |
一种功能增强的通用型car-t细胞及其制备方法和用途
|
|
JP2022518463A
(ja)
*
|
2019-01-16 |
2022-03-15 |
ビーム セラピューティクス インク． |
抗新生物活性および免疫抑制抵抗性の増強を有する改変された免疫細胞
|
|
CN113557036A
(zh)
|
2019-01-18 |
2021-10-26 |
奥泽生物疗法公司 |
基因编辑以改善关节功能
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
MX2021009640A
(es)
|
2019-02-12 |
2021-10-13 |
Pact Pharma Inc |
Composiciones y metodos para la identificacion de celulas t especificas de antigenos.
|
|
SG11202108346WA
(en)
|
2019-02-13 |
2021-08-30 |
Beam Therapeutics Inc |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
AU2020226893B2
(en)
|
2019-02-21 |
2025-02-27 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to T cell related cancer cells and uses thereof
|
|
GB2597851B
(en)
|
2019-02-21 |
2024-05-29 |
Marengo Therapeutics Inc |
Antibody molecules that bind to NKP30 and uses thereof
|
|
CA3130825A1
(en)
|
2019-02-22 |
2020-08-27 |
Garvan Institute Of Medical Research |
Methods of modulating immune response via snvs of a20 that can "tune" the immune system of a subject
|
|
CN109913501B
(zh)
*
|
2019-03-01 |
2022-08-16 |
华东师范大学 |
一种靶向cd152的复制缺陷性重组慢病毒car-t转基因载体及构建方法
|
|
CN111676195A
(zh)
*
|
2019-03-11 |
2020-09-18 |
北京卡替医疗技术有限公司 |
一种治疗t细胞肿瘤的ucar免疫细胞
|
|
WO2020188348A2
(en)
*
|
2019-03-18 |
2020-09-24 |
Ludwig Institute For Cancer Research Ltd |
A2/ny-eso-1 specific t cell receptors and uses thereof
|
|
EP3942043A2
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
BR112021018684A2
(pt)
*
|
2019-03-21 |
2021-11-23 |
Allogene Therapeutics Inc |
Métodos para aumentar a eficiência de esgotamento de células tcr¿¿+
|
|
WO2020206248A1
(en)
|
2019-04-03 |
2020-10-08 |
Precision Biosciences, Inc. |
Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
AU2020267057A1
(en)
|
2019-04-30 |
2021-11-18 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
|
|
US11642409B2
(en)
|
2019-06-26 |
2023-05-09 |
Massachusetts Insttute of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
CN112430575B
(zh)
*
|
2019-08-26 |
2024-01-19 |
深圳市菲鹏生物治疗股份有限公司 |
通用型car-t细胞及其制备方法、应用以及抗肿瘤药物
|
|
MX2022002763A
(es)
|
2019-09-06 |
2022-04-06 |
Crispr Therapeutics Ag |
Linfocitos t modificados por ingenieria genetica que tienen persistencia mejorada en cultivo.
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
CN115279398B
(zh)
*
|
2019-09-27 |
2025-07-04 |
比姆医疗股份有限公司 |
治疗液态癌症的组合物和方法
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
AR120470A1
(es)
*
|
2019-11-13 |
2022-02-16 |
Crispr Therapeutics Ag |
Métodos para fabricar células t car
|
|
AU2020382219A1
(en)
*
|
2019-11-13 |
2022-05-12 |
Crispr Therapeutics Ag |
Manufacturing process for making T cells expressing chimeric antigen receptors
|
|
CN120905142A
(zh)
*
|
2019-11-20 |
2025-11-07 |
卡瑟里克斯私人有限公司 |
用于提供具有增强功能的免疫细胞的方法
|
|
US20210155924A1
(en)
*
|
2019-11-27 |
2021-05-27 |
Stitch Bio, Llc |
Methods and compositions for inducing tumor cell death
|
|
JP7670358B2
(ja)
*
|
2020-01-02 |
2025-04-30 |
寧波茂行生物医薬科技有限公司 |
修飾された免疫エフェクター細胞及びその調製方法
|
|
AU2020416273A1
(en)
|
2020-01-03 |
2022-07-28 |
Marengo Therapeutics, Inc. |
Anti-TCR antibody molecules and uses thereof
|
|
WO2021147891A1
(zh)
*
|
2020-01-21 |
2021-07-29 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫效应细胞及其用途
|
|
JP2023511965A
(ja)
*
|
2020-01-23 |
2023-03-23 |
カンステム バイオテック カンパニー リミテッド |
Ｏｆｆ－ｔｈｅ－ｓｈｅｌｆ幹細胞および免疫細胞、それを含む薬学的組成物
|
|
JP2023515270A
(ja)
*
|
2020-04-21 |
2023-04-12 |
テンパス・ラボズ・インコーポレイテッド |
Ｔｃｒ／ｂｃｒプロファイリング
|
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
WO2021221782A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
CN113684258B
(zh)
|
2020-05-18 |
2024-08-20 |
上海赛比曼生物科技有限公司 |
用于检测鼠源tcr转基因拷贝数的试剂盒及方法
|
|
CA3188143A1
(en)
*
|
2020-06-25 |
2021-12-30 |
The Methodist Hospital |
Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapy
|
|
WO2021260186A1
(en)
|
2020-06-26 |
2021-12-30 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
|
WO2022012531A1
(zh)
*
|
2020-07-14 |
2022-01-20 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫细胞的制备方法
|
|
WO2022012591A1
(zh)
*
|
2020-07-15 |
2022-01-20 |
南京北恒生物科技有限公司 |
用于同种异体移植的工程化免疫细胞
|
|
CA3186119A1
(en)
*
|
2020-07-16 |
2022-01-20 |
Orthobio Therapeutics, Inc. |
Gene editing to improve joint function
|
|
WO2022040454A1
(en)
*
|
2020-08-20 |
2022-02-24 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating mesothelin positive cancers
|
|
US12576151B2
(en)
|
2020-09-25 |
2026-03-17 |
Beam Therapeutics Inc. |
Fratricide resistant modified immune cells and methods of using the same
|
|
IL302063A
(en)
*
|
2020-10-13 |
2023-06-01 |
Univ Pennsylvania |
Designation of intracorporeal t cells for messenger RNA medicine
|
|
CN112266899A
(zh)
*
|
2020-10-26 |
2021-01-26 |
北京卡替医疗技术有限公司 |
修饰的免疫细胞及其用途
|
|
WO2022106731A1
(en)
*
|
2020-11-23 |
2022-05-27 |
Ludwig-Maximilians-Universität München |
Cd28-targeting chimeric antigen receptor (car) t cells, methods of generation and uses thereof
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
US11473060B2
(en)
|
2020-12-30 |
2022-10-18 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into NK cells
|
|
CN112899227B
(zh)
*
|
2021-01-14 |
2022-09-13 |
中国科学院微生物研究所 |
一种调控辅助性t细胞功能的方法
|
|
WO2022187406A1
(en)
|
2021-03-03 |
2022-09-09 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and a dgk inhibitor
|
|
CN116964083A
(zh)
|
2021-03-04 |
2023-10-27 |
艾洛基治疗公司 |
用于保护治疗性细胞免于发生同种异体排斥和激活诱导的细胞死亡的FasL表达和FasR基因敲除
|
|
EP4304612A4
(en)
*
|
2021-03-08 |
2025-10-15 |
Univ Pennsylvania |
COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING T-CELL DYSFUNCTION
|
|
US12617864B2
(en)
|
2021-04-12 |
2026-05-05 |
Medgene Therapeutics, Inc. |
Methods of activating and proliferating exhausted CD8 T cells, CD8 T cells with enhanced activity prepared by the same, and uses thereof
|
|
WO2023039586A1
(en)
|
2021-09-10 |
2023-03-16 |
Agilent Technologies, Inc. |
Guide rnas with chemical modification for prime editing
|
|
US20240390493A1
(en)
*
|
2021-09-29 |
2024-11-28 |
The Johns Hopkins University |
Methods and compositions to augment efficacy and reduce toxicity of non-engrafting, cd8-depleted allogenic donor lymphocyte infusions
|
|
EP4413031A1
(en)
|
2021-10-06 |
2024-08-14 |
Miltenyi Biotec B.V. & Co. KG |
Method for targeted gene insertion into immune cells
|
|
IL311570A
(en)
|
2021-10-14 |
2024-05-01 |
Arsenal Biosciences Inc |
Immune cells with common expression chain and logic gate systems
|
|
US20260083848A1
(en)
|
2021-11-03 |
2026-03-26 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
|
CN113980907B
(zh)
*
|
2021-12-24 |
2022-03-15 |
山东兴瑞生物科技有限公司 |
一种抗flt3嵌合抗原受体修饰的t细胞及其在制备治疗aml药物中的应用
|
|
CN114591963B
(zh)
*
|
2022-05-10 |
2022-07-19 |
上海优替济生生物医药有限公司 |
sgRNA及利用其构建GM-CSF(-)细胞的方法
|
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|
|
EP4590818A2
(en)
*
|
2022-09-19 |
2025-07-30 |
Emendobio Inc. |
Biallelic knockout of pdcd1
|
|
EP4615960A1
(en)
|
2022-11-09 |
2025-09-17 |
C3S2 GmbH |
Methods for manufacturing engineered immune cells
|
|
WO2024121426A1
(en)
*
|
2022-12-09 |
2024-06-13 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Method for optimizing t cells for immuno-therapy
|
|
JP2026504616A
(ja)
*
|
2022-12-09 |
2026-02-06 |
リサーチ インスティテュート アット ネーションワイド チルドレン’ズ ホスピタル |
キメラ抗原受容体（ｃａｒ）ｔ細胞及びその使用
|
|
CN121002052A
(zh)
|
2023-02-03 |
2025-11-21 |
C3S2 有限公司 |
用于非病毒生产工程化免疫细胞的方法
|
|
AU2024217219A1
(en)
*
|
2023-02-10 |
2025-09-11 |
Nanjing Bioheng Biotech Co., Ltd |
Function-enhanced cell therapy
|
|
JP2026507228A
(ja)
|
2023-03-03 |
2026-02-27 |
アーセナル バイオサイエンシズ インコーポレイテッド |
Ｐｓｍａ及びｃａ９を標的とするシステム
|
|
WO2025082418A1
(zh)
*
|
2023-10-18 |
2025-04-24 |
苏州沙砾生物科技有限公司 |
一种鉴定靶标的方法及其应用
|
|
WO2026025092A1
(en)
|
2024-07-26 |
2026-01-29 |
Juno Therapeutics, Inc. |
Synthetic promoters for t cell expression
|